Refining and piloting the R3 supervision strategy in substance use disorder treatment programs
Active Project Grant Awarded Last action
- Award ID
- R34DA060419
- Recipient
-
University Of Arkansas For Medical Sciences UEI VDFYLZPJEAV6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,340,716
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date 81% complete
- Place of performance
- Little Rock, AR 72205, USA
Award details come from USAspending.gov.
Description
- Abstract
- Substance use disorders (SUDS) such as addiction to opioids, methamphetamines and alcohol are a significant burden in the US, affecting almost 50 million individuals annually. Community specialty SUD treatment programs ("SUD programs") are a key type of SUD providers and while effective treatments for SUD exist, significant issues in the organization and delivery of SUD programs (e.g., burnout, turnover) undermine the delivery of high-quality services. Clinical supervisors are centrally positioned to support SUD counselors (frontline clinical providers) and ensure high service quality. In order for clinical supervisors to effectively support counselors, they need evidence-based supervision strategies. Currently, supervisors in community SUD programs receive very little training, support, and direction for supervision, and thus their supervision practices are highly variable, raising concern about the effectiveness of clinical supervision as currently provided in these programs. R3 is an evidence-based supervision strategy that can help fill the GAP. The R3 strategy has been developed for child welfare settings where IT improved leadership, climate, and client outcomes. Based on our preliminary formative work with SUD providers in arkansas, the R3 strategy was deemed acceptable and feasible in SUD programs, and had high perceived potential to improve supervision quality, counselor well-being and performance, and client outcomes. Participants thought the core components of the R3 strategy were a good fit for SUD settings and would not require adaptation; however, the language, behavioral examples, and associated materials (e.g., training, manual) would need to be modified for use in SUD settings. The goals of our study are to iteratively modify and refine the R3 supervision strategy for SUD settings (R3-SUD) and pilot IT in SUD residential treatment programs using quality improvement and implementation science tools and approaches. Aim 1 involves partnering with SUD providers to modify and refine the R3 strategy and accompanying materials. Using the evidence-based quality improvement (EBQI) process, we will engage SUD partners in a series of collaborative meetings to review and discuss modification to the R3 strategy and related study materials, and to make key decisions. The output of this work will be a refined R3 strategy for SUD settings (R3-SUD). Aim 2 involves conducting two pilot cycles with 8 supervisors and 35 counselors at 5 SUD residential treatment programs to assess R3-SUD feasibility and acceptability, to examine its impact on key organizational, counselor, and client outcomes, and to document barriers and facilitators for its implementation and sustained use in routine SUD practice. This study will provide key information to inform planning and design of a future large scale (fully powered) study to assess the effectiveness of the R3-SUD strategy in a large sample of SUD programs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $214,616 | |
| Amendment | $214,616 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $227,871 | |
| Amendment | $227,871 | |
| Amendment | $227,871 | |
| Original award | $227,871 |
Show all 11
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Chestnut Health Systems Inc. | $83,517 | |
| Chestnut Health Systems Inc. | $0 | |
| Chestnut Health Systems Inc. | $83,518 | |
| Chestnut Health Systems Inc. | $83,490 |
Quick answers
Who received award R34DA060419?
R34DA060419 was awarded to University Of Arkansas For Medical Sciences by National Institute on Drug Abuse (National Institutes of Health) on July 15, 2024.
How much is award R34DA060419 worth?
$1,340,716 has been obligated on R34DA060419.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award